Use of surrogate endpoints in healthcare policy - Research Database, The University of York

By the same authors

Challenges with Coverage with Evidence Development Schemes for Medical Devices: A Systematic Review
Reckers-Droog, V., Federici, C., Brouwer, W. & Drummond, M. F., 1 Jun 2020
Article in Health Policy and Technology
Should Health Technology Assessment be more patient-centric? If so, how?
Drummond, M. F., Torbica, A. & Tarricone, R., 16 Apr 2020
Article in European Journal of Health Economics
‘Mapping’ health state utility values from non-preference-based measures: a systematic literature review in rare diseases
Meregaglia, M., Whittal, A., Nicod, E. & Drummond, M. F., 10 Mar 2020
Article in Pharmacoeconomics
Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis
Catalá-López, F., Caulley, L., Ridao, M., Hutton, B., Husereau, D., Drummond, M. F., Alonso-Arroyo, A., Pardo-Fernández, M., Bernal-Delgado, E., Meneu, R., Tabarés-Seisdedos, R., Ramón Repullo, J. & Moher, D., 14 Feb 2020
Article in BMJ Open
Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
Corbacho Martín, B., Drummond, M., Santos, R., Jones, E., Borras, J. M., Mestre-Ferrandiz, J., Espin, J., Henry, N. & Prat, A., 5 Feb 2020
Article in The European Journal of Health Economics

From the same journal

Twenty years on: the impact of fragments on drug discovery
Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W. & Jhoti, H., Sep 2016
Review article in Nature Reviews Drug Discovery
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J-P., Chung, C-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E. & Nar, H., 12 Aug 2016
Review article in Nature reviews. Drug discovery

Use of surrogate endpoints in healthcare policy: proposal for consistent adoption of a validation framework

Research output: Contribution to journal › Letter

Full text download(s)

OC MB MD GR ES RT NatureRevDrugDiscovery_Surrogate_final 270416
266 KB, PDF document

Published copy (DOI)

10.1038/nrd.2016.81

Author(s)

O. Ciani
M. Buyse
M.F. Drummond
G. Rasi
E.D. Saad
R.S. Taylor

Department/unit(s)

Centre for Health Economics

Publication details

Journal	Nature Reviews Drug Discovery
Date	Accepted/In press - 26 Apr 2016
Date	Published (current) - 3 Jun 2016
Volume	15
Number of pages	2
Pages (from-to)	1-2
Original language	English

Bibliographical note

© 2016, Nature Publishing Group. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

York staff: edit these data

The York Research Database

By the same authors

Challenges with Coverage with Evidence Development Schemes for Medical Devices: A Systematic Review

Should Health Technology Assessment be more patient-centric? If so, how?

‘Mapping’ health state utility values from non-preference-based measures: a systematic literature review in rare diseases

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries